Kyverna Therapeutics Inc. (KYTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kyverna Therapeutics Inc.

    NASDAQ: KYTX · Real-Time Price · USD
    5.52
    -0.56 (-9.21%)
    At close: Oct 03, 2025, 3:59 PM
    5.54
    0.36%
    After-hours: Oct 03, 2025, 07:59 PM EDT

    Kyverna Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 96.62M 34.65M 37.73M 76.07M
    Short-Term Investments
    		 189.36M 22.9M 13.59M n/a
    Long-Term Investments
    		 n/a n/a 554K 552K
    Other Long-Term Assets
    		 3.39M 3.92M 678K 41K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 4.62M 3.12M 1.93M 1.02M
    Total Current Assets
    		 290.6M 60.66M 53.25M 77.09M
    Property-Plant & Equipment
    		 10.66M 10.61M 12.44M 7.81M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 14.04M 14.53M 13.67M 8.4M
    Total Assets
    		 304.64M 75.19M 66.92M 85.49M
    Account Payables
    		 4.62M 4.36M 1.45M 773K
    Deferred Revenue
    		 n/a n/a 7.66M 6M
    Short-Term Debt
    		 3.94M n/a n/a n/a
    Other Current Liabilities
    		 943K 9.77M 6.82M 7.2M
    Total Current Liabilities
    		 33.76M 19.86M 11.95M 15.93M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 120.68M 78K
    Total Long-Term Liabilities
    		 4.3M 6.16M 128.97M 115.81M
    Total Liabilities
    		 38.06M 26.02M 140.92M 131.74M
    Total Debt
    		 8.24M 9.08M 10.56M 5.55M
    Book Value
    		 266.59M 49.18M -74M -46.25M
    Book Value Per Share
    		 6.95 0.07 -2.87 -1.79
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -263.52M -136.04M -75.68M -46.78M
    Comprehensive Income
    		 105K 4K -26K n/a
    Shareholders Equity
    		 266.59M 49.18M -74M -46.25M
    Total Investments
    		 189.36M 22.9M 13.59M 552K

    Add to Watchlist